Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report

<p>Abstract</p> <p>Introduction</p> <p>Sunitinib, an oral multitargeted tyrosine kinase inhibitor, is widely used in the treatment of renal cell carcinoma and gastrointestinal stromal tumor and has had a variety of adverse events. However, sunitinib-related acute cholec...

Full description

Bibliographic Details
Main Authors: Nakano Kazuhiko, Suzuki Kazumi, Morita Tatsuo
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Journal of Medical Case Reports
Online Access:http://www.jmedicalcasereports.com/content/6/1/69